# Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes

> **NCT00099892** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 544 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** vildagliptin

## Key facts

- **NCT ID:** NCT00099892
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 544 (ACTUAL)
- **Last updated:** 2017-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00099892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00099892, "Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00099892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*